Raquel Ferrer-Oliveras
Overview
Explore the profile of Raquel Ferrer-Oliveras including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
658
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Alijotas-Reig J, Marques-Soares J, Esteve-Valverde E, Miro-Mur F, Belizna C, Udry S, et al.
Arthritis Rheumatol
. 2024 Jan;
76(5):816-817.
PMID: 38200647
No abstract available.
2.
Esteve-Valverde E, Alijotas-Reig J, Belizna C, Marques-Soares J, Anunciacion-Llunell A, Feijoo-Masso C, et al.
Placenta
. 2023 May;
138:20.
PMID: 37146536
No abstract available.
3.
Esteve-Valverde E, Alijotas-Reig J, Belizna C, Marques-Soares J, Anunciacion-Llunell A, Feijoo-Masso C, et al.
Placenta
. 2023 Apr;
136:29-34.
PMID: 37028222
Introduction: Obstetric antiphospholipid syndrome (OAPS) is an autoimmune disease related to antiphospholipid antibodies (aPL) with primaryinflammatory injury followed by clot cascade activation and thrombus formation. Complement system activation and their...
4.
Bonacina E, Armengol-Alsina M, Hurtado I, Garcia-Manau P, Ferrer-Oliveras R, Monreal S, et al.
J Obstet Gynaecol
. 2022 Aug;
42(7):2840-2845.
PMID: 35980876
This is a prospective, observational study, conducted in a tertiary referral hospital. We enrolled 175 singleton pregnancies with estimated foetal weight below the 10th centile between 20 + 0 and...
5.
Bonacina E, Mendoza M, Farras A, Garcia-Manau P, Serrano B, Hurtado I, et al.
BJOG
. 2022 Mar;
129(11):1870-1877.
PMID: 35303394
Objective: The aim of this study was to assess the added value of the soluble fms-like tyrosine kinase-1 (sFlt-1) and placental growth factor (PlGF) ratio for adjusting the periodicity of...
6.
Alijotas-Reig J, Esteve-Valverde E, Ferrer-Oliveras R, Saez-Comet L, Lefkou E, Mekinian A, et al.
Rheumatology (Oxford)
. 2021 Oct;
60(12):5883.
PMID: 34672326
No abstract available.
7.
Alijotas-Reig J, Esteve-Valverde E, Ferrer-Oliveras R, Saez-Comet L, Lefkou E, Mekinian A, et al.
Eur J Anaesthesiol
. 2021 Aug;
38(9):916-922.
PMID: 34397526
Background: The combination of low-dose aspirin (LDA) and low-molecular-weight heparin (LMWH) until the end of gestation are the currently the accepted standard of care for the treatment of antiphospholipid-related obstetric...
8.
Ferrer-Oliveras R, Mendoza M, Capote S, Pratcorona L, Esteve-Valverde E, Cabero-Roura L, et al.
Arch Gynecol Obstet
. 2021 May;
304(1):39-57.
PMID: 33945026
Coronavirus disease-2019 (COVID-19) related to Coronavirus-2 (SARS-CoV-2) is a worldwide health concern. Despite the majority of patients will evolve asymptomatic or mild-moderate upper respiratory tract infections, 20% will develop severe...
9.
Mendoza M, Ferrer-Oliveras R, Bonacina E, Garcia-Manau P, Rodo C, Carreras E, et al.
Am J Perinatol
. 2020 Jul;
38(14):1472-1479.
PMID: 32615618
Objective: This study aimed to analyze the effect of pravastatin on angiogenic factors, feto-maternal Doppler findings and pregnancy outcomes in women with early-onset fetal growth restriction (FGR) treated with pravastatin...
10.
Alijotas-Reig J, Esteve-Valverde E, Ferrer-Oliveras R, Saez-Comet L, Lefkou E, Mekinian A, et al.
Rheumatology (Oxford)
. 2019 Oct;
59(6):1306-1314.
PMID: 31580459
Objectives: To compare clinical features, laboratory data and fetal-maternal outcomes between 1000 women with obstetric APS (OAPS) and 640 with aPL-related obstetric complications not fulfilling Sydney criteria (non-criteria OAPS, NC-OAPS)....